Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie

Regeneron Pharmaceuticals: Neues Kursziel

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…

Top 5 NASDAQ Genetics Stocks of 2023

The genetics sector supports every other life science industry in a variety of ways.One of its major contributions is the…

Top 5 NASDAQ Genetics Stocks (Updated March 2023)

The genetics sector supports every other life science industry in a variety of ways.One of its major contributions is the…

Regeneron Pharmaceuticals: Kursziel verbessert

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von TD Cowen stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…

: Replimune shares plunge as skin cancer therapy fails to meet primary clinical-trial goals

Replimune Group Inc. shares REPL dropped more than 40% premarket on Tuesday after the biotech company said an investigational cancer…

Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 35th Annual Healthcare Conference (Transcript)

…

Regeneron Pharmaceuticals: Positive Ergebnisse aus der zweiten Phase-3-Studie für Dupixent - Aktienanalyse

New York (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von Jefferies & Co: Akash Tewari, Analyst von Jefferies & Co, stuft die Aktie von…

Oncology Drug Discovery & Development Market Expected to Grow at a CAGR of 18.2% from 2023 to 2031 | Reveals InsightAce Study

Companies covered in this study are Novartis, AstraZeneca, Merck & Co., Inc, Bristol-Myers Squibb, Pfizer, Eli Lilly and Company, Gilead…

Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies London Healthcare Conference (Transcript)

…

Regeneron Pharmaceuticals, Inc. (REGN) Presents at Truist Securities BioPharma Symposium (Transcript)

…

Regeneron Pharmaceuticals Inc. (REGN) UBS Biopharma Conference (Transcript)

…

Regeneron Pharmaceuticals: Kursziel erhöht

Milwaukee (www.aktiencheck.de) - Rating-Update: Die Analysten von Robert W. Baird stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…

Regeneron Pharmaceuticals: Neues Kursziel

London (www.aktiencheck.de) - Rating-Update: Barclays stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol: RGO, NASDAQ-Symbol: REGN) weiterhin…

Regeneron Pharmaceuticals: Canaccord erhöht Kursziel und rät zum Kauf - Aktienanalyse

Vancouver (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von Canaccord Genuity: Die Analysten von Canaccord Genuity stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN:…

Regeneron Pharmaceuticals: Hochstufung! Positive Dynamik bis 2024 erwartet - Aktienanalyse

St. Petersburg (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von Raymond James: Dane Leone, Analyst von Raymond James, stuft in einer aktuellen Aktienanalyse die…

Regeneron Pharmaceuticals, Inc. (REGN) Q3 2023 Earnings Call Transcript

…

Regeneron Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation

…

Regeneron Reports Third Quarter 2023 Financial and Operating Results

TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for…

Reneo Pharmaceuticals: Buy Before Upcoming Pivotal Data Drop

…

How to Invest in Genetics (Updated 2023)

Genetics is the study of genes, their variations and hereditary characteristics, as well as how these traits are passed on…

Regeneron Announces Investor Conference Presentations

TARRYTOWN, N.Y., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…

Aktie von Regeneron Pharmaceuticals läuft heute schlechter (750,7140 €)

Die Aktie von Regeneron Pharmaceuticals notiert heute ein wenig leichter. Zuletzt zahlten Investoren für das Wertpapier 799,11 US-Dollar. Heute hat…

Regeneron and Sanofi Provide Update on Dupixent® (dupilumab) sBLA for Chronic Spontaneous Urticaria

TARRYTOWN, N.Y. and PARIS, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today…

Regeneron Pharmaceuticals: "buy"

Vancouver (www.aktiencheck.de) - Rating-Update: Die Analysten von Canaccord Genuity bewerten die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol:…

Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit

IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company…

Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases

TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Intellia Therapeutics,…

Regeneron Pharmaceuticals: BofA erhöht Kursziel - Aktienanalyse

Charlotte (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von BofA Securities: Die Analysten von BofA Securities stufen in einer aktuellen Aktienanalyse die Aktie von…

Regeneron to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on November 2, 2023

TARRYTOWN, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will…

Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss

TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has…

Transforming Skin Care: Atopic Eczema Treatment Market Size Predicted to Flourish to USD 13 Billion by 2030, with a 7.14% CAGR

[219 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global…

Regeneron Pharmaceuticals: Neues Kursziel

New York (www.aktiencheck.de) - Rating-Update: Jasper Hellweg, Analyst von Argus Research, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN:…

: Regeneron CFO Landry to retire, top accountant Fenimore to become CFO

Regeneron Pharmaceuticals Inc. REGN said late Friday that Chief Financial Officer Robert E. Landry will retire in February, and…

Insiderhandel: EVP & General Mgr, Industrial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 5.216.071$

Van Plew Daniel P. - Vorstand - Tag der Transaktion: 2023-08-24...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 10.314.829$

Poon, Christine A. - Aufsichtsrat - Tag der Transaktion: 2023-08-23...…

Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 188.212$

Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-08-23...…

The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis Pharmaceuticals and Fulcrum Therapeutics

Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis Pharmaceuticals and Fulcrum Therapeutics are part of the Zacks top Analyst Blog....…

Is Regeneron Stock a Buy Now?

The companys growth fuel isnt running out yet....…

Regeneron Announces Investor Conference Presentations

TARRYTOWN, N.Y., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…

Regeneron Pharmaceuticals: Kursziel angehoben

San Francisco (www.aktiencheck.de) - Rating-Update: Mohit Bansal, Analyst von Wells Fargo Advisors, bewertet die Aktie von Regeneron Pharmaceuticals Inc. (ISIN:…

Regeneron Awarded $326M Government Contract For COVID-19 Antibody Therapy Development

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) was awarded a government contract valued at up to $326 million on Tuesday. read more...…

Regeneron Pharmaceuticals: Kursziel erhöht

London (www.aktiencheck.de) - Rating-Update: Die Analysten von Barclays stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol: RGO,…

Canaccord ups Regeneron to buy, sees high-dose Eylea re-igniting sales

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron, J&J receive millions to develop new COVID therapies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron, J&J Get US Funding to Develop New Covid Vaccines ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron gets federal funding for next-generation COVID treatment

Regeneron Pharmaceuticals Inc. REGN said Tuesday that the Biomedical Advanced Research and Development Authority has agreed to support the development,…

Regeneron enters $326 mln pact with US to develop new COVID therapy

...Aug 22 (Reuters) - Regeneron Pharmaceuticals on Tuesday said it had......…

Regeneron Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 Prevention

Program is part of U.S. Governments Project NextGen and provides partial funding for clinical development of a novel monoclonal antibody…

dpa-AFX ProFeed